Digest Network Come funziona
Network
/
Società
En
Non verificato

Enigma Biomedical USA

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteScienza

4 comunicati stampa

Guarda tutti i comunicati
14/08/2026
Industria
Igiene alimentare
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Enigma Biomedical USA Announces FDA Approval of TAUKLARIFY™ (florquinitau F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease
Fonte
Enigma Biomedical USA
Emittente
Business Wire
1.00
0
25/11/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Associazioni/Professionisti
Industria
Enigma Biomedical USA awarded a grant from The Michael J. Fox Foundation for Discovery and Development of Novel α-Synuclein PET Imaging Biomarker
Fonte
Enigma Biomedical USA
Emittente
Business Wire
1.00
0
02/12/2024
Mercato del lavoro
Psichiatria
Scienza
Biotecnologia
Medicina nucleare
Salute
Oncologia
Enigma Biomedical USA Announces Formation of Scientific Advisory Board
Fonte
Enigma Biomedical USA
Emittente
Business Wire
1.00
0
09/09/2024
Mercato del lavoro
Industria
Salute
Scienza
Farmaceutica
Biotecnologia
Enigma Biomedical - USA Announces Collaboration with Alamar Biosciences to Advance the Field of Diagnostics for Neurodegenerative Diseases
Fonte
Enigma Biomedical USA
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0